Inactive Instrument

Calendar NEOPROBE OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding	CI
2023	Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

2302e8ea19.6brxoY2-nBB6RdAbbYIxXL5Fa2nNVWi1XbWClx8EfxE.o9DDkPf08H8TIpVCWPZ8auwJBCL0EynnZPPwoHBLDUiojoOM-vjZTyMdpw~0283a1ede38001e63d9b91b9204983d2

2024-08-06	Q2 2024 Earnings Release (Projected)
2024-11-05	Q3 2024 Earnings Release (Projected)

2024-05-06	Q1 2024 Earnings Release (Projected)
2023-11-16 13:00	Annual General Meeting
2023-11-13	Q3 2023 Earnings Release
2023-07-27 13:00	Extraordinary Shareholders Meeting
2023-06-07 16:00	Q1 2023 Earnings Release
2023-03-21 17:00	Q4 2022 Earnings Call
2023-03-21 16:01	Q4 2022 Earnings Release
2022-12-08 13:00	Annual General Meeting
2022-11-15 17:00	Q3 2022 Earnings Call
2022-11-14 08:00	Q3 2022 Earnings Release
2022-11-10 09:00	Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161
2022-11-09	American College of Rheumatology Convergence Conference
2022-09-08 16:00	Interim 2022 Earnings Call
2022-08-15 08:30	Interim 2022 Earnings Release
2022-06-11 21:00	Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197
2022-05-12 17:00	Q1 2022 Earnings Call
2022-05-12 07:30	Q1 2022 Earnings Release
2022-04-20 17:00	NAV3-32 Phase 2B Study Results Call
2022-04-14 17:00	Business Update Call
2022-03-23 17:00	FY 2021 Earnings Call

Fiscal Period	December	2018	2019	2020
Net sales Million USD	Released Forecast Spread	1,17	0,66 0,77 -14.18%	0,92 0,90 2.18%
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	0,00	-11,0 -11,0 0.09%	-10,7 -12,1 11.2%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.17%	-10,7 -12,1 11.02%
Net income Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.16%	-11,4 -12,1 5.51%
EPS USD	Released Forecast Spread	-1,80	-0,76 -0,74 -3.4%	-0,48 -0,48 0%
Announcement Date		-	11/03/20	24/03/21

Fiscal Period	December	2021 Q3
Net sales Million USD	Released Forecast Spread	0,10 0,00 -
EBIT Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Net income Million USD	Released Forecast Spread	-2,44 -3,52 30.8%
EPS USD	Released Forecast Spread	-0,08 -0,11 27.27%
Announcement Date		10/11/21

2024-05-20	ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00	EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-21	CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
2024-05-21	EVOTEC SE: Q1 2024 Earnings Release
2024-06-30	IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
2024-07-15 01:45	ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)

2024-05-17 02:00	BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05	CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14	GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05	NUVATION BIO INC.: Q1 2024 Earnings Release
2024-05-14 07:30	ABSCI CORPORATION: Q1 2024 Earnings Release
2024-05-14 01:50	BELITE BIO, INC: Q1 2024 Earnings Release
2024-05-13	POLARIS GROUP: Q1 2024 Earnings Release
2024-05-13 16:30	AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-13 07:00	APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-12 19:00	PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release